PFS
LYRA

Prospera Financial Services’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Prospera Financial Services’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2
Closed – – 2186
2022
Q1 		$0 Buy
+2
New +$439 ﹤0.01% 2762

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Prospera Financial Services's LYRA Position: Q2 2022 in Review

Prospera Financial Services sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2022, closing a stake of 2 shares.

Prospera Financial Services first reported a position in LYRA in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 36 funds tracked by Wall St. Rank hold LYRA as of Q2 2022.

  • Prospera Financial Services reported no remaining LYRA THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 2 LYRA THERAPEUTICS INC shares in Q2 2022.
  • Prospera Financial Services first reported a position in LYRA THERAPEUTICS INC in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's LYRA THERAPEUTICS INC position peaked at $0 in Q1 2022.
  • 36 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.